Ergoteles’s National Healthcare NHC Stock Holding History

Ergoteles’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,412	Closed	-$2.23M	–	1342
2023 Q1	$2.23M	Buy	+38,412	New	+$2.21M	0.09%	240

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles's NHC Position: Q2 2023 in Review

Ergoteles sold out of National Healthcare (NHC) in Q2 2023, closing a stake of 38,412 shares — an estimated $2.23M sold.

Ergoteles first reported a position in NHC in Q1 2023 and held it in 1 quarter. The position peaked at $2.23M in Q1 2023. 132 funds tracked by Wall St. Rank hold NHC as of Q2 2023.

Ergoteles reported no remaining National Healthcare position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 38,412 National Healthcare shares in Q2 2023, an estimated $2.23M.
Ergoteles first reported a position in National Healthcare in Q1 2023 and held it in 1 quarter.
Ergoteles's National Healthcare position peaked at $2.23M in Q1 2023.
132 funds tracked by Wall St. Rank held National Healthcare as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.